1
|
Raymond J, Parrein P, Barat E, Chenailler C, Decreau-Gaillon G, Varin R, Joly LM. Pharmacist tracking and correction of medication errors: An improvement project in the observation ward of the emergency department. Ann Pharm Fr 2023; 81:1007-1017. [PMID: 37356662 DOI: 10.1016/j.pharma.2023.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 06/19/2023] [Accepted: 06/21/2023] [Indexed: 06/27/2023]
Abstract
OBJECTIVE The risk of medication errors is high in emergency departments. Implementation of medication reconciliation activity complemented by pharmaceutical analysis of prescription is an effective way to reduce drug related problems. This study aimed to assess the potential clinical impact of these activities to prevent medication errors for the observation ward patients. The secondary objective was to assess these activities' cost-avoidance and benefit-to-cost ratio. MATERIAL AND METHODS This study was conducted in a 16-bed unit, over a 5-month period. The patients' demographic and treatment details, and data from pharmaceutical activities were collected and analyzed by a pharmacist. Two pharmacists and an emergency physician assessed the potential clinical impact of medication errors. RESULTS Medication reconciliation for 250 patients (15.7% of 1589 admitted patients) and pharmaceutical analysis of prescription for 302 patients (19%) were performed by the pharmacist. Medication reconciliation detected 752 errors in 197 patients; 19% were related to high-risk medications and 14% had a potential clinical impact assessed as major, critical or fatal. Pharmaceutical analysis of prescription revealed 159 drug related problems in 118 patients; of which 26% involved high-risk medications and 24% had a potential clinical impact assessed "at least major". In total, 16% of pharmacist interventions had a potential clinical impact assessed "at least major" in 33% of patients: this represents 1.8 pharmacist interventions formulated per day. CONCLUSION The presence of a pharmacist in the observation ward of the emergency department is useful in detecting iatrogenic drug related problems and reducing their medical impact. The benefit-to-cost ratio is favorable for the hospital.
Collapse
Affiliation(s)
- Johanna Raymond
- Pharmacy Department, CHU Rouen, Rouen, France; Observation ward, Adult Emergency Department, CHU Rouen, 76000 Rouen, France.
| | | | - Eric Barat
- Pharmacy Department, CHU Rouen, Rouen, France
| | | | | | - Rémi Varin
- Pharmacy Department, CHU Rouen, Rouen, France
| | - Luc-Marie Joly
- Observation ward, Adult Emergency Department, CHU Rouen, 76000 Rouen, France
| |
Collapse
|
2
|
Abouchouar I, Hindlet P, Ratsimbazafy C, Fernandez C, Schwab C. [Medication reconciliation and hospital-community transition securisation: Survey of community pharmacists]. Ann Pharm Fr 2023; 81:875-881. [PMID: 36754347 DOI: 10.1016/j.pharma.2023.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 01/25/2023] [Accepted: 01/30/2023] [Indexed: 02/09/2023]
Abstract
OBJECTIVE To collect the community pharmacists' perception on their role in the medication reconciliation's process. METHODS We did an observational transverse study thanks to a survey of community pharmacists working in France, conducted in 2020. A digital questionnaire was submitted to Parisian community pharmacists before being shared on two Facebook groups. The responses were analysed with Microsoft Excel® software. We calculated percentages, used Chi2 or Fisher's exact tests and did qualitative analyses. RESULTS We collected the perception of 135 community pharmacists, the majority was women (80%), relatively young (69.6% of 40 years old or less). They were 63.7% to claim knowing the medication reconciliation, but they could not define it properly. The subject's knowledge was statistically related to age (P-value<0.001) and previous contacts of the health care facilities (P-value<0.001). The majority of interviewed pharmacist considered the transmission of information to those health facilities as relevant and feasible and they expressed their willingness to get involved. However, they were limited by some obstacles such as the non-exhaustiveness of the medicinal record, the unsecured mail and the lack of feedbacks. CONCLUSIONS Although the community pharmacists expressed interest for the medication reconciliation process and willingness to get involved, their role remained limited. Therefore, this process needs an improvement of its organisation and a generalisation of its practice to really benefit the hospital-community transition's safety.
Collapse
Affiliation(s)
- I Abouchouar
- Département de pharmacie clinique, faculté de pharmacie, université Paris-Saclay, 91400 Orsay, France
| | - P Hindlet
- Département de pharmacie clinique, faculté de pharmacie, université Paris-Saclay, 91400 Orsay, France; Hôpital Saint-Antoine, pharmacie, AP-HP, GHU Sorbonne université, INSERM, institut Pierre-Louis d'épidémiologie et de santé publique, Sorbonne université, 75012 Paris, France
| | - C Ratsimbazafy
- Hôpital Saint-Antoine, pharmacie, GHU, Sorbonne université, AP-HP, 75012 Paris, France
| | - C Fernandez
- Département de pharmacie clinique, faculté de pharmacie, université Paris-Saclay, 91400 Orsay, France; Hôpital Saint-Antoine, pharmacie, AP-HP, GHU Sorbonne université, INSERM, institut Pierre-Louis d'épidémiologie et de santé publique, Sorbonne université, 75012 Paris, France
| | - C Schwab
- Département de pharmacie clinique, faculté de pharmacie, université Paris-Saclay, 91400 Orsay, France; Hôpital Saint-Antoine, pharmacie, AP-HP, GHU Sorbonne université, INSERM, institut Pierre-Louis d'épidémiologie et de santé publique, Sorbonne université, 75012 Paris, France.
| |
Collapse
|
3
|
Kabac T, Le Tohic S, Spadoni S. [Medication reconciliation on admission: One year of practice in health care institutions during the COVID-19 pandemic]. Ann Pharm Fr 2023; 81:863-874. [PMID: 36731628 PMCID: PMC9886383 DOI: 10.1016/j.pharma.2023.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2022] [Revised: 01/11/2023] [Accepted: 01/20/2023] [Indexed: 02/02/2023]
Abstract
OBJECTIVES Medication reconciliation is a key point of the v2020 certification. The main objective of this study was to evaluate this activity over one year, including the first epidemic wave at COVID-19. The secondary objectives were to identify the obstacles and levers and to evaluate doctor satisfaction. METHODS This was a retrospective study of drug reconciliations performed on admission during 12 months of the emergence of COVID-19. Patients aged 65 years and older from orthopedic and visceral surgery, acute hospitalization and conventional medicine units were included. Unintentional discrepancies were analyzed. The obstacles and levers were identified by means of a focus group. Doctors' satisfaction was collected using online quiz. RESULTS A total of 760 patients were conciliated, of which 27% (n=208) by hospital pharmacy technicians. A decrease in activity was observed during the first epidemic wave. An unintentional discrepancy was found in 77% of patients, and only 48% were corrected by the prescriber. These results were impacted by the pandemic. The pharmaceutical team was mobilized in the logistical management of the crisis, but it was able to adapt in order to perpetuate the activity. Doctors are satisfied with the process. CONCLUSIONS Medication reconciliation on admission is essential for the prevention of iatrogeny, particularly with the impact of the COVID-19 pandemic in healthcare institutions.
Collapse
Affiliation(s)
- T Kabac
- Service de pharmacie, hôpital d'instruction des armées Laveran, 34, boulevard Laveran, 13013 Marseille, France.
| | - S Le Tohic
- Service de pharmacie, hôpital d'instruction des armées Laveran, 34, boulevard Laveran, 13013 Marseille, France
| | - S Spadoni
- Service de pharmacie, hôpital d'instruction des armées Laveran, 34, boulevard Laveran, 13013 Marseille, France
| |
Collapse
|
4
|
André D, Chatain C, Chaumais MC, Rieutord A, Roy S. [Pharmaceutical cares as means of prevention against drug iatrogenic: Case of oral anticoagulant]. Ann Pharm Fr 2021:S0003-4509(21)00128-0. [PMID: 34481783 DOI: 10.1016/j.pharma.2021.08.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2021] [Revised: 08/23/2021] [Accepted: 08/27/2021] [Indexed: 11/22/2022]
Abstract
Oral anticoagulant can have a significant risk of adverse events, particularly when it is initiated, modified or interrupted. Pharmaceutical care through medication reconciliation could improve the benefit-to-risk ratio of these drugs. A prospective and interventional single center study was conducted from March through August 2018 in medicine and surgical units. Patients with an oral anticoagulant prescribed and coming from outpatient sector were included. These patients received a medication reconciliation at admission and discharge. Frequency and type of discrepancies were studied. Their gravity rating was assessed using the Cornish et al. scale. This study included 162 patients. The medication reconciliation at the admission allowed the detection of 133 unintentional discrepancies which 16 of them represented a high risk for the patient included nine errors about oral anticoagulant prescribing. Concerning the reconciliation at discharge, 51 unintentional discrepancies had been detected: 12 of them represented a high risk for the patient included eight errors about oral anticoagulant prescription. The acceptance rate of the discrepancies was 86% and reflected discrepancies severity. This result reached 96.4% if we took into account discrepancies with a severe clinical impact. This study highlighted oral anticoagulant represented relevant prioritization criteria to the long-lasting implementation of pharmaceutical care. This secures the management of the patient since the admission until the hospital discharge. The last step of our approach would be to study the needs about data transmission to the community caregivers.
Collapse
|
5
|
Duval M, Satori D, Al Wazzan N, Chidiac A, Lao S. [Medical reconciliation for hospitalized patients in orthopedic surgery department: Return of experience over 2 years of practice]. Ann Pharm Fr 2021:S0003-4509(21)00044-4. [PMID: 33785371 DOI: 10.1016/j.pharma.2021.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Revised: 03/16/2021] [Accepted: 03/18/2021] [Indexed: 11/20/2022]
Abstract
OBJECTIVES Some medication errors can be prevented by pharmacist action such as medication reconciliation. The main objective of this study was to evaluate the medication reconciliation activity after two years of practice. The secondary objective was to assess the medical staff's satisfaction following the setting up of the activity. METHODS This retrospective study was realized over a period of two years in our hospital. Patients meeting the following criteria were included: 65 years and over, hospitalized in orthopedic surgery department, preferentially after a discharge of the emergency room. After the best possible medication history was established, it is compared to medicines ordered. The discrepancies were defined as intended or unintended. Study data were collected and analyzed using Excel and SPSS statistics®. RESULTS A total of 899 patients met the inclusion criteria during the study period, mean age was 78 years (27; 104). A total of 84 % of our cohort was admitted after a discharge of the emergency room. Seventy five percent of the population had at least an unintended discrepancie, a mean of 2,3 unintended discrepancies per patient was identified. Seventy five percent of the unintended discrepancy were discussed and resolved. The medical staff was mostly satisfied of the activity. CONCLUSION The medication reconciliation secured the drug management of hospitalized patients.
Collapse
|
6
|
Leherle A, Kowal C, Toulemon Z, Dalle-Pecal M, Pelissolo A, Leboyer M, Paul M, Diviné C. [Is the medication reconciliation achievable and relevant in Psychiatry?: Feedback on the implementation of medication reconciliation on hospital admission]. Ann Pharm Fr 2019; 78:252-263. [PMID: 31796266 DOI: 10.1016/j.pharma.2019.10.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2019] [Revised: 10/25/2019] [Accepted: 10/30/2019] [Indexed: 10/25/2022]
Abstract
OBJECTIVE The health care pathway of patients suffering from mental disorders is complex and includes a risk of interruption of treatment. We implemented medication reconciliation at patients' admission to mental health care service in February 2017. The aim of this study was to achieve a feedback experience answering our questions about the feasibility and relevance of this process. METHOD A prospective analysis of medication reconciliations over the first 7 months of implementation was carried out according to 3 activity indicators and 6 performance indicators. RESULTS A total of 39 patients were reconciled and 56.4 % of them were in enforced hospitalization unit. All patients were interviewed by the pharmacist. Collected information during this interview was concordant with at least one of the other sources in 70.4 % of the cases. Thirteen patients were not reconciled within 72h after their admission because of their psychiatric pathology. The average number of unintentional medication discrepancy (UMD) detected was 0.97 per reconciled patient. The rate of major gravity UMD was 23.7 %. The number of UMDs per patient was significantly higher in enforced hospitalization unit (P<0.05). UMDs were essentially related to somatic drugs (81.6 %). Nearly 95 % of the detected UMDs resulted in a modification of prescription. CONCLUSION These results show that medication reconciliation at patients' admission is feasible and relevant in psychiatry. To limit constraints related to psychiatric pathology, we propose to perform medication reconciliation of patients more than 72 hours after patient admission provided that their clinical condition allows it.
Collapse
Affiliation(s)
- A Leherle
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - C Kowal
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - Z Toulemon
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - M Dalle-Pecal
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - A Pelissolo
- Pôle de psychiatrie, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly 94000 Créteil, France.
| | - M Leboyer
- Pôle de psychiatrie, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly 94000 Créteil, France.
| | - M Paul
- Service pharmacie, hôpitaux universitaires Henri-Mondor AP-HP, 51, avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France.
| | - C Diviné
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| |
Collapse
|
7
|
Mosnier-Thoumas S, Videau MN, Lafargue A, Martin-Latry K, Salles N. [Benefit of the geriatric mobile unit's intercession on the quality of medical prescriptions for the elderly: Past year assessment]. Ann Pharm Fr 2018; 77:136-145. [PMID: 30392589 DOI: 10.1016/j.pharma.2018.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 10/15/2018] [Accepted: 10/16/2018] [Indexed: 10/27/2022]
Abstract
Our multidisciplinary geriatric mobile unit works in behalf of the frail elderly people, aged at least 75, who are in loss of self-reliance. One of its main aims is so optimize medical prescriptions. The purpose of this study was to show the benefit of geriatrician and pharmacist interventions over the quality of medical prescriptions for the elderly. Medication reconciliation of treatment and reassessment of the appropriateness of the prescriptions was systematically carried out. The problems related to drug therapy have been listed and classified according to the criteria of pharmaceutical interventions defined by the French Society of Clinical Pharmacy (SFPC). Out of 181 patients, 86,2% had potentially an inappropriate or sub-optimal prescription. Finally, 462 optimizations were proposed (2.9±1.9 by patients): 204 withdrawals, 166 additions, 58 dosage adaptations, 21 therapeutic follow-ups and 13 modalities of administration. This reassessment of the prescriptions allowed to develop between our geriatric mobile unit and the liberal professionals a communication focused on the therapeutic optimization and to spread recommendations on the proper use of drugs in the elderly population.
Collapse
Affiliation(s)
- S Mosnier-Thoumas
- Unité mobile de gériatrie, pôle de gérontologie clinique, CHU de Bordeaux, hôpital Xavier Arnozan, avenue du Haut-Lévêque, 33604 Pessac, France.
| | - M-N Videau
- Unité mobile de gériatrie, pôle de gérontologie clinique, CHU de Bordeaux, hôpital Xavier Arnozan, avenue du Haut-Lévêque, 33604 Pessac, France
| | - A Lafargue
- Unité mobile de gériatrie, pôle de gérontologie clinique, CHU de Bordeaux, hôpital Xavier Arnozan, avenue du Haut-Lévêque, 33604 Pessac, France
| | - K Martin-Latry
- Pôle cardio-thoracique, centre d'exploration, de prévention et de traitement de l'athérosclérose, échographie vasculaire (CEPTA), CHU de Bordeaux, avenue du Haut-Lévêque, 33604 Pessac, France
| | - N Salles
- Médecine gériatrique, pôle de gérontologie clinique, CHU de Bordeaux, avenue du Haut-Lévêque, 33604 Pessac, France
| |
Collapse
|
8
|
Bravo P, Martinez L, Metzger S, Da Costa Noble E, Meckenstock R, Greder-Belan A, Parnet L, Samdjee F, Azan S. [Medication reconciliation in a department of internal medicine and infectious and tropical diseases: Feedback after one year practice]. Rev Med Interne 2018; 40:291-296. [PMID: 30172598 DOI: 10.1016/j.revmed.2018.08.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2017] [Revised: 07/03/2018] [Accepted: 08/01/2018] [Indexed: 10/28/2022]
Abstract
Since April 2015, medication reconciliation is performed in our Department. The objective of this study is to assess the impact of this activity on patients' care after one year of practice. METHODS All patients who received medication reconciliation between April-October 2015 and June-December 2016 were included in this retrospective study. Undocumented unintentional discrepancies (DNIND) which result from the comparison between the patient's usual treatments and the medication prescribed at admission were collected. Then, a multidisciplinary discussion was initiated to correct them. The gravity of each DNIND was determined a posteriori. RESULTS A statistical comparison between the two studies (2015 vs. 2016) showed the following significant results: decrease in DNIND (0.9 vs. 0.43), in percentage of patients with at least one DNIND (43% vs 31% P <5.10-6), in reconciliation time (43min vs. 23min) and no significant difference in the distribution of DNIND typology. The main therapeutic classes are: metabolism-diabetes-nutrition (21%), cardiology (18%), pneumology (17%) and neurology-psychiatry (15%). Drugs mainly concerned with DNIND are inhaled anti-asthmatics (13% of the medicines with DNIND), vitamins (8% of DNIND) and the levetiracetam antiepileptic drug (5% of DNIND). CONCLUSION The implementation of the reconciliation medication allowed a significant reduction of the DNIND that permits to improve the patient healthcare pathway.
Collapse
Affiliation(s)
- P Bravo
- Pharmacie, centre hospitalier de Versailles, 177, rue de Versailles, 78150, 78150 Le Chesnay, France.
| | - L Martinez
- Pharmacie, centre hospitalier de Versailles, 177, rue de Versailles, 78150, 78150 Le Chesnay, France
| | - S Metzger
- Pharmacie, centre hospitalier de Versailles, 177, rue de Versailles, 78150, 78150 Le Chesnay, France
| | - E Da Costa Noble
- Pharmacie, centre hospitalier de Versailles, 177, rue de Versailles, 78150, 78150 Le Chesnay, France
| | - R Meckenstock
- Médecine interne et maladies infectieuses, centre hospitalier de Versailles, 78150 Le Chesnay, France
| | - A Greder-Belan
- Médecine interne et maladies infectieuses, centre hospitalier de Versailles, 78150 Le Chesnay, France
| | - L Parnet
- Gériatrie aiguë polyvalente, centre hospitalier de Versailles, 78150 Le Chesnay, France
| | - F Samdjee
- Pharmacie, centre hospitalier de Versailles, 177, rue de Versailles, 78150, 78150 Le Chesnay, France
| | - S Azan
- Pharmacie, centre hospitalier de Versailles, 177, rue de Versailles, 78150, 78150 Le Chesnay, France
| |
Collapse
|
9
|
Flamme-Obry F, Belaiche S, Hazzan M, Ramdan N, Noël C, Odou P, Décaudin B. [Clinical pharmacist and medication reconciliation in kidney transplantation]. Nephrol Ther 2018; 14:91-98. [PMID: 29477279 DOI: 10.1016/j.nephro.2017.04.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2017] [Revised: 03/30/2017] [Accepted: 04/04/2017] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Drug related problems (DRP) can lead to severe consequences in kidney recipients. The aim of the study was to assess the impact of the clinical pharmacist interventions on the incidence of DRP. METHOD The number of DRP were evaluated according to 3periods: Without intervention, with medication reconciliation at admission, and with medication reconciliation at admission associated with an interview with the clinical pharmacist at discharge. RESULTS Patients concerned were mainly men, 55years old (median age), stage3 of CKD, transplanted for less than 3months or more than 1year, with cardiovascular risk factors and receiving an average of 9drugs/day. Among the DRP, 20% were avoidable and severe in most cases. In period1, 27.7% patients had at least 1DRP, in period2, 21.3% patients had at least 1DRP, and in period3, 17.4% of patients had at least 1DRP (P=0.03). One hundred and ten patients had medication reconciliation at admission with a mean of 0.6unintentional discrepancies per patient (omission in 81% of cases). The main drugs involved concerned the digestive-metabolic (24.5%), cardiovascular (23%), and nervous (23%) system. Sixty-eight interviews at discharge were realized and revealed self-medication habits. CONCLUSION Our study shows that medication reconciliation at admission associated with an interview with the clinical pharmacist at discharge can help to reduce DRP in kidney recipients. Further studies are needed to confirm our results.
Collapse
Affiliation(s)
| | - Stéphanie Belaiche
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59000 Lille, France; EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, University Lille, 59000 Lille, France.
| | - Marc Hazzan
- Service de néphrologie, CHRU de Lille, 59000 Lille, France; Inserm U995, Lille Inflammation Research International Center (LIRIC), University Lille, 59000 Lille, France
| | - Nassima Ramdan
- EA 2694, santé publique : épidémiologie et qualité des soins, CHRU de Lille, University Lille, 59000 Lille, France
| | - Christian Noël
- Service de néphrologie, CHRU de Lille, 59000 Lille, France; Inserm U995, Lille Inflammation Research International Center (LIRIC), University Lille, 59000 Lille, France
| | - Pascal Odou
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59000 Lille, France; EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, University Lille, 59000 Lille, France
| | - Bertrand Décaudin
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59000 Lille, France; EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, University Lille, 59000 Lille, France
| |
Collapse
|
10
|
Drancourt P, Atkinson S, Lebel D, Bussières JF. [Assessment of perception about medication reconciliation among healthcare professionals at Saint-Justine hospital]. Ann Pharm Fr 2016; 74:304-16. [PMID: 26739918 DOI: 10.1016/j.pharma.2015.11.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2015] [Revised: 11/16/2015] [Accepted: 11/19/2015] [Indexed: 10/22/2022]
Abstract
OBJECTIVES Our main objective is to assess nurses and doctors perception about medication reconciliation. METHODS This is a descriptive and cross-sectional study. We have created three surveys, one for each health worker (nurses, doctors, resident, pharmacists). Each survey consists of single or multi-choice closed questions. A four-point Likert scale was used to collect the perception. Descriptive statistics have been calculated. RESULTS A total of 114 nurses, 98 doctors and residents and 26 pharmacists from all care services, replied to the survey. The majority of doctors (58%), pharmacists (60%) and nurses (52%) recognized the relevance and utility of medication reconciliation in healthcare safety. However, few healthcare professionals (6% of doctors, 13% of nurses et 46% of pharmacists) know that medication reconciliation is a required organizational practice. Only 25% of doctors always consult the best possible medication history after a patient admission while the majority do not use it because of unreliability issues. So, there have been some major changes to optimize medication reconciliation process in our hospital. CONCLUSION This study shows a increasing interest to medication reconciliation by healthcare professionals. However, the use of medication reconciliation remains marginal.
Collapse
Affiliation(s)
- P Drancourt
- Unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, Côte-Sainte-Catherine, H3T 1C5 Montréal, QC, Canada
| | - S Atkinson
- Unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, Côte-Sainte-Catherine, H3T 1C5 Montréal, QC, Canada
| | - D Lebel
- Unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, Côte-Sainte-Catherine, H3T 1C5 Montréal, QC, Canada
| | - J-F Bussières
- Unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, Côte-Sainte-Catherine, H3T 1C5 Montréal, QC, Canada; Faculté de pharmacie, université de Montréal, CP 6128, succursale Centre-ville, H3C 3J7 Montréal, QC, Canada.
| |
Collapse
|
11
|
Boyé F, Sallerin B, Ah Kang F, Arnaud A, Kantambadouno JB, Amar J, Chamontin B, Bouhanick B. [Place of clinical pharmacist in the management of drugs in patients with hypertension]. Ann Cardiol Angeiol (Paris) 2015; 64:216-21. [PMID: 26051854 DOI: 10.1016/j.ancard.2015.04.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2015] [Accepted: 04/28/2015] [Indexed: 11/17/2022]
Abstract
PURPOSE To synthesize pharmacists' interventions made in the department of internal medicine and hypertension of university hospital of Toulouse and assess the impact on medication orders. METHODS This is a single-center, prospective study using pharmacists' interventions recorded between September 2013 and March 2014 on the Act-IP(©) website of the French Society of Clinical Pharmacy. The clinical pharmacist is present everyday in the unit to establish the medication reconciliation of new patients (the process of comparing a patient's medication orders to all of the medications that the patient has been taking), and analysis of medication orders. When a risk of iatrogenic drug is identified, a therapeutic change is proposed to the prescriber. RESULTS A total of 2491 medication orders were analyzed for 7 months, leading to 39 pharmacists' interventions (1.6 pharmacists' interventions per 100 medication orders). The most commonly identified drug-related problems were improper administration (33%, n=13), not prescribed drug (21%, n=8), non-conformity to guidelines (18%, n=7), supratherapeutic dose (15%, n=6), and 13% (n=5) targeted prescribed treatment not administered, underdosing, incorrect administration or drug interaction. The most relevant molecules were atorvastatin (10%), bromazepam (8%) and levothyroxine (8%) and only 2 interventions targeted antihypertensive drugs. The rate of physicians' acceptance was 92%. CONCLUSION Pharmacists' interventions mainly concern the co-prescriptions of antihypertensive drugs and very few antihypertensive drugs. The clinical pharmacist contributes to preventing iatrogenic in patients with hypertension with a very good acceptance by the clinician.
Collapse
Affiliation(s)
- F Boyé
- Pôle pharmacie, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France.
| | - B Sallerin
- Pôle pharmacie, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - F Ah Kang
- Service de médecine interne et HTA, pôle cardiovasculaire et métabolique, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - A Arnaud
- Pôle pharmacie, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - J B Kantambadouno
- Service de médecine interne et HTA, pôle cardiovasculaire et métabolique, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - J Amar
- Service de médecine interne et HTA, pôle cardiovasculaire et métabolique, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - B Chamontin
- Service de médecine interne et HTA, pôle cardiovasculaire et métabolique, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - B Bouhanick
- Service de médecine interne et HTA, pôle cardiovasculaire et métabolique, hôpital Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| |
Collapse
|